TOYA SMITH: Open Payments
NPI 1114485877 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 6 payments from 6 companies in 2025. Trend: 2023 $592 · 2024 $613 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Ethicon US, LLC | 1 | $113 |
| Intra-Sana Laboratories | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: FANAPT, REZDIFFRA, UZEDY, Echelon Flex, RELTONE 200 MG, CAPLYTA.
Industry payments across LA — which companies pay providers there.
